No Data
Daré Bioscience to Host Third Quarter 2025 Financial Results and Company Update Conference Call and Webcast on November 13, 2025
Daré Bioscience Advances Progesterone Delivery Study for Preterm Birth Prevention
Daré Bioscience's Ovaprene Study: A New Era in Contraceptive Innovation
Express News | Dare Bioscience Inc - Daré Exploring Strategic Partnerships for Platform Expansion
Oral Contraceptive Pills Market Size to Reach US$ 38.16 Bn by 2033, Driven by Rising Awareness & Accessibility
Daré Bioscience Secures Up To ~$499K From Gates Foundation To Support Preeclampsia Research Through Mentorship And Project Management